Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Sep;18(3):448–453. doi: 10.1128/aac.18.3.448

Prophylaxis against enterococcal endocarditis: comparison of the aminoglycoside component of parenteral antimicrobial regimens.

J Murillo, H C Standiford, H P Holley, B A Tatem, E S Caplan
PMCID: PMC284021  PMID: 7425612

Abstract

Prophylactic antibiotics for the prevention of enterococcal endocarditis are recommended for patients with valvular heart disease undergoing surgery or instrumentation of the genitourinary and gastrointestinal tracts. To evaluate the most active aminoglycoside antibiotic to include in these regimens, we administered streptomycin, gentamicin, or amikacin, each in combination with ampicillin, to six healthy adult volunteers in a crossover manner. When the sera from the volunteers were tested for bactericidal activity against 16 strains of enterococci, the gentamicin-ampicillin combination produced higher serum bactericidal levels for a longer duration of time against more strains than the other two regimens. At 1 h after antibiotic administration (a time when surgical procedures are likely to be performed), mean geometric bactericidal titers against the enterococci were 1: 7.0 for the gentamicin-ampicillin regimen, as compared with 1:3.6 and 1:3.2 for the streptomycin-ampicillin and amikacin-ampicillin combinations, respectively. Despite the lower serum levels for gentamicin, we feel that this aminoglycoside should be used in combination with ampicillin for prophylactic regimens against enterococcal endocarditis.

Full text

PDF
448

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOUNT J. G. BACTERIAL ENDOCARDITIS. Am J Med. 1965 Jun;38:909–922. doi: 10.1016/0002-9343(65)90010-0. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carrizosa J., Kaye D. Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits. Antimicrob Agents Chemother. 1977 Oct;12(4):479–483. doi: 10.1128/aac.12.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corrigall D., Bolen J., Hancock E. W., Popp R. L. Mitral valve prolapse and infective endocarditis. Am J Med. 1977 Aug;63(2):215–222. doi: 10.1016/0002-9343(77)90235-2. [DOI] [PubMed] [Google Scholar]
  5. Durack D. T., Starkebaum M. K., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis. J Lab Clin Med. 1977 Jul;90(1):171–179. [PubMed] [Google Scholar]
  6. Edberg S. C., Bottenbley C. J., Gam K. Use of sodium polyanethol sulfonate to selectively inhibit aminoglycoside and polymyxin antibiotics in a rapid blood level antibiotic assay. Antimicrob Agents Chemother. 1976 Mar;9(3):414–417. doi: 10.1128/aac.9.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Everett E. D., Hirschmann J. V. Transient bacteremia and endocarditis prophylaxis. A review. Medicine (Baltimore) 1977 Jan;56(1):61–77. [PubMed] [Google Scholar]
  8. Facklam R. R., Padula J. F., Thacker L. G., Wortham E. C., Sconyers B. J. Presumptive identification of group A, B, and D streptococci. Appl Microbiol. 1974 Jan;27(1):107–113. doi: 10.1128/am.27.1.107-113.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Krogstad D. J., Korfhagen T. R., Moellering R. C., Jr, Wennersten C., Swartz M. N. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism. J Clin Invest. 1978 Aug;62(2):480–486. doi: 10.1172/JCI109149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lerner P. I., Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med. 1966 Feb 3;274(5):259–contd. doi: 10.1056/NEJM196602032740506. [DOI] [PubMed] [Google Scholar]
  11. Markiewicz W., Stoner J., London E., Hunt S. A., Popp R. L. Mitral valve prolapse in one hundred presumably healthy young females. Circulation. 1976 Mar;53(3):464–473. doi: 10.1161/01.cir.53.3.464. [DOI] [PubMed] [Google Scholar]
  12. Moellering R. C., Jr, Weinberg A. N. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest. 1971 Dec;50(12):2580–2584. doi: 10.1172/JCI106758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moellering R. C., Jr, Wennersten C., Weinberg A. N. Synergy of penicillin and gentamicin against Enterococci. J Infect Dis. 1971 Dec;124 (Suppl):S207–S209. doi: 10.1093/infdis/124.supplement_1.s207. [DOI] [PubMed] [Google Scholar]
  14. Murillo J., Standiford H. C., Tatem B. A., Caplan E. S., Calia F. M. Parenteral prophylaxis against enterococcal endocarditis. Am J Med Sci. 1979 Mar-Apr;277(2):195–200. doi: 10.1097/00000441-197903000-00008. [DOI] [PubMed] [Google Scholar]
  15. Procacci P. M., Savran S. V., Schreiter S. L., Bryson A. L. Prevalence of clinical mitral-valve prolapse in 1169 young women. N Engl J Med. 1976 May 13;294(20):1086–1088. doi: 10.1056/NEJM197605132942004. [DOI] [PubMed] [Google Scholar]
  16. Shinebourne E. A., Cripps C. M., Hayward G. W., Shooter R. A. Bacterial endocarditis 1956-1965: analysis of clinical features and treatment in relation to prognosis and mortality. Br Heart J. 1969 Sep;31(5):536–542. doi: 10.1136/hrt.31.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zimmermann R. A., Moellering R. C., Jr, Weinberg A. N. Mechanism of resistance to antibiotic synergism in enterococci. J Bacteriol. 1971 Mar;105(3):873–879. doi: 10.1128/jb.105.3.873-879.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES